دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Flashback Foreword: Chemoradiotherapy for Nasopharyngeal Carcinoma.
Gillison, Maura L. MD, PhD 1,2,,
doi : 10.1200/JCO.23.00932
Volume 41(24) pgs. 3963-4061,e63-e72 August 20, 2023
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
Al-Sarraf, M; LeBlanc, M; Giri, P G; Fu, K K; Cooper, J; Vuong, T; Forastiere, A A; Adams, G; Sakr, W A; Schuller, D E; Ensley, J F
doi : 10.1200/JCO.22.02764
Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Jackson, Emily B. MD, FRCPC 1,2; Chia, Stephen K.L. MD, FRCPC 1,2,,
doi : 10.1200/JCO.23.00759
Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms.
Cliff, Edward R. Scheffer MBBS, MPH 1,2,,; Kesselheim, Aaron S. MD, JD, MPH 1,2,; Feldman, William B. MD, DPhil, MPH 1,2
doi : 10.1200/JCO.22.02675
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang, Michael L. MD 1,,; Jurczak, Wojciech MD, PhD 2,; Zinzani, Pier Luigi MD, PhD 3,4,; Eyre, Toby A. MD, MBChB, DipMedEd, MRCP, FRCPath 5,; Cheah, Chan Y. MD 6,7,; Ujjani, Chaitra S. MD 8,; Koh, Youngil MD 9,; Izutsu, Koji MD, PhD 10,; Gerson, James N. MD 11,; Flinn, Ian MD, PhD 12,; Tessoulin, Benoit MD 13,; Alencar, Alvaro J. MD 14,; Ma, Shuo MD, PhD 15,; Lewis, David PhD, MBChB 16,; Lech-Maranda, Ewa MD, PhD 17; Rhodes, Joanna MD 18,19,; Patel, Krish MD 20,; Maddocks, Kami MD 21,; Lamanna, Nicole MD 22,; Wang, Yucai MD, PhD 23,; Tam, Constantine S. MD 24,; Munir, Talha MBBS 25,; Nagai, Hirokazu MD, PhD 26,; Hernandez-Ilizaliturri, Francisco MD 27,; Kumar, Anita MD 28,; Fenske, Timothy S. MD, MS 29,; Seymour, John F. PhD, MBBS, FRACP 24,; Zelenetz, Andrew D. MD, PhD 28,; Nair, Binoj PhD 30,; Tsai, Donald E. MD, PhD 30,; Balbas, Minna PhD 30,; Walgren, Richard A. MD, PhD 30,; Abada, Paolo MD, PhD 30,; Wang, Chunxiao PhD 31,; Zhao, Junjie PhD 30,; Mato, Anthony R. MD, MSCE 28,; Shah, Nirav N. MD 29,
doi : 10.1200/JCO.23.00562
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma.
Robert, Caroline MD, PhD 1,,; Carlino, Matteo S. PhD, MBBS 2,; McNeil, Catriona MBBS, PhD 3; Ribas, Antoni MD, PhD 4,; Grob, Jean-Jacques MD 5,; Schachter, Jacob MD 6; Nyakas, Marta MD 7,; Kee, Damien DMedSc, MBBS 8,; Petrella, Teresa M. MD 9,; Blaustein, Arnold MD 10; Lotem, Michal MD 11,; Arance, Ana MD, PhD 12,; Daud, Adil I. MD 13,; Hamid, Omid MD 14,; Larkin, James PhD 15,; Anderson, James PhD 16,; Krepler, Clemens MD 16,; Grebennik, Dmitri MD 16; Long, Georgina V. PhD, MBBS 17,
doi : 10.1200/JCO.22.01599
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
Kalinsky, Kevin MD, MS 1,; Accordino, Melissa K. MD, MS 2; Chiuzan, Codruta PhD 3; Mundi, Prabhjot S. MD 2; Sakach, Elizabeth MD 1; Sathe, Claire MD 2; Ahn, Heejoon MS 3; Trivedi, Meghna S. MD, MS 2; Novik, Yelena MD 4; Tiersten, Amy MD 5; Raptis, George MD 6; Baer, Lea N. MD 7; Oh, Sun Y. MD 8; Zelnak, Amelia B. MD 9; Wisinski, Kari B. MD 10; Andreopoulou, Eleni MD 11; Gradishar, William J. MD 12; Stringer-Reasor, Erica MD 13; Reid, Sonya A. MD 14; O'Dea, Anne MD 15; O'Regan, Ruth MD 16; Crew, Katherine D. MD, MS 2; Hershman, Dawn L. MD, MS 2
doi : 10.1200/JCO.22.02392
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Tolaney, Sara M. MD, MPH 1,,; Chan, Arlene MBBS 2,; Petrakova, Katarina MD, PhD 3,; Delaloge, Suzette MD 4,; Campone, Mario MD, PhD 5,; Iwata, Hiroji MD, PhD 6,; Peddi, Parvin F. MD 7,; Kaufman, Peter A. MD 8,; De Kermadec, Elisabeth MD, MPH 9,; Liu, Qianying PhD 9,10,; Cohen, Patrick MD 11,; Paux, Gautier MSc 9,; Wang, Lei PhD 9,; Ternes, Nils PhD 12,; Boitier, Eric PhD 12,; Im, Seock-Ah MD, PhD 13,
doi : 10.1200/JCO.22.02746
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study.
Ruppert, Reinhard MD 1; Junginger, Theodor MD 2,; Kube, Rainer MD 3; Strassburg, Joachim MD 4; Lewin, Andreas MD 5; Baral, Joerg MD 6; Maurer, Christoph A. MD 7,8; Sauer, Joerg 9,; Lauscher, Johannes MD 10,; Winde, Guenther MD 11; Thomasmeyer, Rena MD 12; Stelzner, Sigmar MD 13,14,; Bambauer, Cornelius MD 15; Scheunemann, Soenke MD 16; Faedrich, Axel 17; Wollschlaeger, Daniel PhD 18; Merkel, Susanne MD 19
doi : 10.1200/JCO.22.02166
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Michalski, Jeff M. MD, MBA 1,,; Winter, Kathryn A. MS 2; Prestidge, Bradley R. MD 3,; Sanda, Martin G. MD 4; Amin, Mahul MD 5,; Bice, William S. PhD 6; Gay, Hiram A. MD 1; Ibbott, Geoffrey S. PhD 7; Crook, Juanita M. MD 8,; Catton, Charles N. MD 9,; Raben, Adam MD 10,; Bosch, Walter DSc 1,; Beyer, David C. MD 11,; Frank, Steven J. MD 7; Papagikos, Michael A. MD 12,; Rosenthal, Seth A. MD 13; Barthold, H. Joseph MD 14; Roach, Mack III MD 15,; Moughan, Jennifer MS 2; Sandler, Howard M. MD 16,
doi : 10.1200/JCO.22.01856
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.
Flores-Toro, Joseph A. PhD 1; Jagu, Subhashini PhD 1,; Armstrong, Gregory T. MD, MSCE 2,; Arons, David F. JD 3; Aune, Gregory J. MD, PhD 4,; Chanock, Stephen J. MD 1; Hawkins, Douglas S. MD 5,; Heath, Allison PhD 6; Helman, Lee J. MD 7,; Janeway, Katherine A. MD, MMSc 8,; Levine, Jason E. MD 1; Miller, Ellyn BS 9; Penberthy,
doi : 10.1200/JCO.22.02208
Market, Gift, Everyday Ethics, and Emmanuel Levinas in Patient Care.
Astrow, Alan B. MD 1,
doi : 10.1200/JCO.23.00419
Do All Patients Diagnosed With Cancer Deserve Germline Testing?.
Sorscher, Steven MD
doi : 10.1200/JCO.23.00710
Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenstrom's Macroglobulinemia?.
Sarosiek, Shayna MD; Treon, Steven P. MD, PhD; Branagan, Andrew R. MD, PhD; Castillo, Jorge J. MD
doi : 10.1200/JCO.23.00649
Reply to S. Sarosiek et al.
Buske, Christian MD; Dimopoulos, Meletios A. MD, PhD; Morel, Pierre MD
doi : 10.1200/JCO.23.00877
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2
Owen, Dwight H. MD, MS 1,,; Singh, Navneet MD, DM 2; Ismaila, Nofisat MD, MSc 3,; Masters, Gregory MD 4; Riely, Gregory J. MD, PhD 5,; Robinson, Andrew G. MD 6,; Schneider, Bryan J. MD 7,; Jaiyesimi, Ishmael A. DO, MS 8
doi : 10.1200/JCO.23.01055
